Dr William Steadman Farmer, MD in Vestavia Hls, AL - Medicare Dermatology

Dr William Steadman Farmer, MD is a medicare enrolled "Dermatology" physician in Vestavia Hls, Alabama. He went to Georgetown University School Of Medicine and graduated in 2018 and has 6 years of diverse experience with area of expertise as Dermatology. He is a member of the group practice Christopher B Harmon Md Pc and his current practice location is 1940 Stonegate Dr Ste 130, Vestavia Hls, Alabama. You can reach out to his office (for appointments etc.) via phone at (256) 351-1874.

Dr William Steadman Farmer is licensed to practice in Alabama (license number MD.44360) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1396242244.

Contact Information

	Dr William Steadman Farmer, MD
	1940 Stonegate Dr Ste 130, Vestavia Hls, AL 35242-2541
	(256) 351-1874
	Not Available

Physician's Profile

Full Name	Dr William Steadman Farmer
Gender	Male
Speciality	Dermatology
Experience	6 Years
Location	1940 Stonegate Dr Ste 130, Vestavia Hls, Alabama
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr William Steadman Farmer attended and graduated from Georgetown University School Of Medicine in 2018

NPI Data:

NPI Number: 1396242244
Provider Enumeration Date: 04/08/2018
Last Update Date: 10/19/2022

Medicare PECOS Information:

PECOS PAC ID: 7315283710
Enrollment ID: I20220623001576

Medical Identifiers

Medical identifiers for Dr William Steadman Farmer such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1396242244	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207N00000X	Dermatology	MD.44360 (Alabama)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Christopher B Harmon Md Pc	9436211463	29

News Archive

Keryx does not meet primary endpoint in perifosine + capecitabine Phase 3 trial for colorectal cancer

Keryx Biopharmaceuticals, Inc. reported today that the Phase 3 "X-PECT" clinical trial evaluating perifosine (KRX-0401) + capecitabine (Xeloda) in patients with refractory advanced colorectal cancer did not meet the primary endpoint of improving overall survival versus capecitabine + placebo.

Study raises questions about effectiveness of campaigns projected to improve health literacy

A joint study by Indiana University and Columbia University researchers found no change in prejudice and discrimination toward people with serious mental illness or substance abuse problems despite a greater embrace by the public of neurobiological explanations for these illnesses.

State highlights: N.H. hospital in Hepatitis outbreak must allow access to patient records

A New Hampshire judge says a hospital tied to a hepatitis C outbreak must grant public health officials broad access to patient records. Exeter Hospital had argued it would be violating state and federal law if it provided unfettered access to its records system. But a Merrimack County Superior Court judge on Thursday sided with the state.

Celimmune licenses anti-IL-15 monoclonal antibody from Amgen

Celimmune LLC, a clinical development-stage immunotherapy company focused on treating and preventing autoimmune diseases, announced today that it has licensed a Phase 2-stage, anti-IL-15 monoclonal antibody (AMG 714) from Amgen.

Republicans talk strategy to repeal – or revise – health law

Republicans do not have enough seats to marshal through a full repeal if Democrats remain steadfast in their support. Even if Republicans were able to sway enough Democrats to support their effort, it would face a certain veto from Obama.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr William Steadman Farmer allows following entities to bill medicare on his behalf.

Entity Name	Christopher B Harmon Md Pc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1477708642 PECOS PAC ID: 9436211463 Enrollment ID: O20081229000234

News Archive

Keryx does not meet primary endpoint in perifosine + capecitabine Phase 3 trial for colorectal cancer

Study raises questions about effectiveness of campaigns projected to improve health literacy

State highlights: N.H. hospital in Hepatitis outbreak must allow access to patient records

Celimmune licenses anti-IL-15 monoclonal antibody from Amgen

Republicans talk strategy to repeal – or revise – health law

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr William Steadman Farmer is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr William Steadman Farmer, MD 1940 Stonegate Dr Ste 130, Vestavia Hls, AL 35242-2541 Ph: (256) 351-1874	Dr William Steadman Farmer, MD 1940 Stonegate Dr Ste 130, Vestavia Hls, AL 35242-2541 Ph: (256) 351-1874

News Archive

Keryx does not meet primary endpoint in perifosine + capecitabine Phase 3 trial for colorectal cancer

Study raises questions about effectiveness of campaigns projected to improve health literacy

State highlights: N.H. hospital in Hepatitis outbreak must allow access to patient records

Celimmune licenses anti-IL-15 monoclonal antibody from Amgen

Republicans talk strategy to repeal – or revise – health law

Dermatology Doctors in Vestavia Hls, AL

Ragan Lowe, PA-C Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1940 Stonegate Dr Ste 130, Vestavia Hls, AL 35242 Phone: 205-977-9876
Dr. John Wuennenberg, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1940 Stonegate Dr Ste 130, Vestavia Hls, AL 35242 Phone: 205-977-9876
Jonathan A Cappel, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1940 Stonegate Dr Ste 130, Vestavia Hls, AL 35242 Phone: 205-977-9876 Fax: 205-977-9976
Brian James King, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1940 Stonegate Dr Ste 130, Vestavia Hls, AL 35242 Phone: 205-977-9876
Christopher Barry Harmon, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1940 Stonegate Dr Ste 130, Vestavia Hls, AL 35242 Phone: 205-977-9876 Fax: 205-977-9976
Seth Michael Martin, Dermatology Medicare: Medicare Enrolled Practice Location: 1940 Stonegate Dr Ste 130, Vestavia Hls, AL 35242 Phone: 205-977-9876 Fax: 205-968-3901

Dr William Steadman Farmer, MD - Medicare Dermatology in Vestavia Hls, AL

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Keryx does not meet primary endpoint in perifosine + capecitabine Phase 3 trial for colorectal cancer

Study raises questions about effectiveness of campaigns projected to improve health literacy

State highlights: N.H. hospital in Hepatitis outbreak must allow access to patient records

Celimmune licenses anti-IL-15 monoclonal antibody from Amgen

Republicans talk strategy to repeal – or revise – health law

Medicare Reassignments

Keryx does not meet primary endpoint in perifosine + capecitabine Phase 3 trial for colorectal cancer

Study raises questions about effectiveness of campaigns projected to improve health literacy

State highlights: N.H. hospital in Hepatitis outbreak must allow access to patient records

Celimmune licenses anti-IL-15 monoclonal antibody from Amgen

Republicans talk strategy to repeal – or revise – health law

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Keryx does not meet primary endpoint in perifosine + capecitabine Phase 3 trial for colorectal cancer

Study raises questions about effectiveness of campaigns projected to improve health literacy

State highlights: N.H. hospital in Hepatitis outbreak must allow access to patient records

Celimmune licenses anti-IL-15 monoclonal antibody from Amgen

Republicans talk strategy to repeal – or revise – health law

Dermatology Doctors in Vestavia Hls, AL